 |
|
Home | Celgene Given “Outperform” Rating at BMO Capital Markets (CELG) |
 |
Celgene Given “Outperform” Rating at BMO Capital Markets (CELG)
|
 |
- December 10, 2012
-
Celgene (NASDAQ: CELG)‘s stock had its “outperform” rating reiterated by investment analysts at BMO Capital Markets in a note issued to investors on Monday. They currently have a $90.00 target price on the stock. Celgene traded up 2.33% on Monday, hitting $80.51. Celgene has a 52-week low of $58.53 and a 52-week high of $81.24. [...]This article (Celgene Given “Outperform” Rating at BMO Capital Markets (CELG)) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://www.americanbankingnews.com/2012/12/10/celgene-given-outperform-rating-at-bmo-capital-markets-celg/
|
 |
|
 |
|
 |
